comparemela.com

Latest Breaking News On - Responsive auto regulatory element - Page 4 : comparemela.com

Astellas and Taysha Gene Therapies Announce Strategic Investment to Support Development of Taysha s AAV-based Gene Therapy Programs

- Taysha Gene Therapies is an emerging leader in the development of AAV gene therapies; new collaboration aimed at enhancing development of two of Taysha s.

United statesNorth carolinaSouth san franciscoSan franciscoKenji yasukawaNaoki okamuraEuropean commissionDrug administrationExchange commissionAstellas pharma incTaysha gene therapies incAstellas centerUt southwestern gene therapy programGene therapiesTaysha boardAstellas pharma

Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

11.08.2022 - TSHA-120 treated patients in GAN demonstrated durable improvement and recoverability of sensory nerve amplitude potential (SNAP), a definitive clinical endpoint, compared to natural history TSHA-120 commercial grade and clinical trial material .

United statesKimberly leeCompany contactEuropean commissionExchange commissionTaysha gene therapies incDevelopment rd expensesCorporate affairsUt southwestern gene therapy programGene therapiesResponsive auto regulatory elementGene therapy programPrivate securities litigation reform actAnnual reportQuarterly reportConsolidated statements

Taysha Gene Therapies, Inc (TSHA) Q1 2022 Earnings Call Transcript

TSHA earnings call for the period ending March 31, 2022.

United statesKimberly leeJack allenRachel baileyGil blum needhamKamran alamYun zhongLaura chico wedbushElizabeth webster goldman sachsYanan zhuJoon leeSalveen richterGil blumKevin degeeter oppenheimerLaura chicoSarah sinnett

Taysha Pauses Programs, Cuts Workforce to Extend Cash Runway

Taysha Pauses Programs, Cuts Workforce to Extend Cash Runway
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Gene therapiesResponsive auto regulatory element

Taysha Gene Therapies, Inc (TSHA) Q4 2021 Earnings Call Transcript

TSHA earnings call for the period ending December 31, 2021.

Kimberly leeSuyash prasadCarsten bonnemannKamran alamExchange commissionHereditary neuropathy foundationTaysha gene therapies incAssociation centers of excellenceTaysha gene therapiesCorporates affairChief executiveMedical officerCharcot marie tooth association centersResponsive auto regulatory element

vimarsana © 2020. All Rights Reserved.